Harvard Business School (HBS) Executive Education will hold a new program, Leading an Enduring Science-Based Business, on the HBS campus November 17 – 20, 2019.
Designed for senior executives, scientists, and decision-makers – especially CEOs, CFOs, Chief Medical Officers, Chief Science Officers, and their direct reports, as well as board members and business-unit heads – from life-science companies (such as pharmaceuticals and biotechnology) and health-care organizations (such as insurers, institutes, and regulators), the program explores how advances in science change the way science-based organizations are funded, managed, and commercialized. It addresses ways to work collaboratively across functions to effectively manage an organization and successfully navigate these changes.
According to Amitabh Chandra, Henry and Allison McCance Professor of Business Administration, Ethel Zimmerman Wiener Professor of Public Policy and Director of Health Policy Research, Harvard Kennedy School, and Faculty Chair of Leading an Enduring Science-Based Business, “To effectively lead life-sciences companies, managers need to think differently about science and know what questions to ask of their scientists. This program is structured so that we spend the morning on the latest, greatest, and most-promising advances, and then we spend the afternoon thinking through the business strategy that revolves around scientific discovery and scientific insights.”
* What is the cost of capital and what does that mean for R&D?
* How are clinical trials financed?
* What are the sources of funding and what are the constraints and expectations?
* Can the timelines of science and commerce be reconciled?
* What happens when cutting-edge research conflicts with corporate mission and culture?
* What is the impact of regulatory policy on business strategy?
* Understanding outcomes-based pricing and contracting – How does one design a value-based contract? What are the milestones?
* How is an asset scientifically evaluated?
* How do I develop an organizational structure that plans appropriately for human capital and resource allocation?
* How do I weigh generic licensing against existing customers and shareholders? Sharing knowledge vs. revenue stream?
For more information on Leading and Enduring Science-Based Business, visit HBS online.
Albert & Company International, Inc. is a unique consultancy and Web publishing service for Executive Development and Advanced Management. Our vision is to help individuals gain the knowledge they need to excel, thereby increasing their efficiency and productivity, leading to better organizational growth. For more information on this and many other courses in our extensive Executive Education database, the most comprehensive and complete of its kind, visit us on the Web at http://albertconsulting.com, or email us at email@example.com.